Conyers Dill & Pearman provided Cayman Islands and BVI legal advice to Jacobson Pharma Corporation Limited in connection with its HKD$752.5 million IPO on the Main Board of The Hong Kong Stock Exchange.
Jacobson Pharma Corporation Limited is a leading pharmaceutical company and the largest provider of generic drugs in Hong Kong.
Partner Anna Chong of Conyers’ Hong Kong office advised on the matter, working alongside Shearman & Sterling and Commerce & Finance Law Offices.
